comparemela.com

Page 6 - Kellie Hanson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wound-Healing Tech Innovator Nanomedic Technologies Appoints Prof Jan Plock and Mark Darty to Advisory Board

Share this article Share this article LOD, Israel, Feb. 23, 2021 /PRNewswire/  Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, today announced the appointment of two new members to its Advisory Board: Prof. Jan Plock, MD, an international authority in microsurgery, burn reconstruction, and wound healing; and Mark Darty, a serial entrepreneur with over three decades experience in technology innovation, commercialization, and operations management. Plock and Darty join Nanomedic as the company is expanding commercial availability of its flagship product, the Spincare System, to healthcare facilities across Europe. Spincare is the first CE-cleared portable electrospinning wound treatment device on the market, and Nanomedic has also begun preparations to enter the U.S. market.

Wound-Healing Tech Innovator Nanomedic Technologies Appoints Prof Jan Plock and Mark Darty to Advisory Board

Wound-Healing Tech Innovator Nanomedic Technologies Appoints Prof Jan Plock and Mark Darty to Advisory Board
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Veterans Affairs (VA) Signs Agreement with Theranica to Make Nerivio® Acute Migraine Therapeutic Device Available to Veterans

Veterans Affairs (VA) Signs Agreement with Theranica to Make Nerivio® Acute Migraine Therapeutic Device Available to Veterans USA - English News provided by Share this article Share this article MONTCLAIR, N.J., Feb. 16, 2021 /PRNewswire/  Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced it has signed a Federal Supply Schedule (FSS) agreement with the United States Department of Veterans Affairs (VA), that will enable Veterans access to Nerivio®, a wearable for acute treatment of migraine.   Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses, said Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine. Providing headache care to both Veterans and non-Veterans, it has been my experience that Veterans tend to live with migraine and related headache disorder

Rambam Hospital Adopts Nanomedic s Wound-Healing Spincare System

Share this article Share this article LOD, Israel, Feb. 2, 2021 /PRNewswire/  Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, today announced that Rambam Health Care Campus, the primary hospital for northern Israel, has selected the Spincare Wound Care System to enhance patient care and improve its ability to heal wounds and burns. Nanomedic s Spincare Wound Care System in use at Rambam Health Care Campus Rambam Health Care Campus is a 1,000-bed academic hospital serving more than 2 million residents of Northern Israel. Using the Spincare System, physicians at Rambam have treated to date dozens of patients suffering from a variety of burns ranging in size and severity. 

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform

Share this article Share this article BINYAMINA, Israel, Jan. 19, 2021 /PRNewswire/  OncoHost, global leader in host response profiling for improved personalized cancer therapy, today announced the completion of a $8 million Series B funding round. The funding will help finance OncoHost s ongoing clinical trials, open a US-based affiliate and prepare for the upcoming launch of PROphet ®, the company s machine learning-based Host Response Profiling platform that combines proteomic analysis with AI to predict patient response to immunotherapy, providing clinicians with potential combination strategies to overcome treatment resistance. The funding round was led by OurCrowd, an investment platform built for accredited investors and institutions to invest in start-ups, early-stage companies and venture funds. They were joined by a group of family offices and private investors.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.